[*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed but]
[*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed but]
[China Zenix Filed Annual Report on Form 20-F for 2011 ZHANGZHOU, China, April 26, 2012 China Zenix Auto International Limited About China Zenix Auto International Limited China Zenix Auto International Limited is the largest commercial vehicle wheel manufacturer in China in both the aftermarket and OEM market by sales volume. With a large intellectual property portfolio, the Company offers]
[] [[Cozen O’Connor Letterhead] April 27, 2012 Skystar Bio-Pharmaceutical Company 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xi’an, Shaanxi Province, P.R. China Re: Registration Statement on Form S-8 In rendering this opinion, we have examined: (i) the Articles of Incorporation and By-laws of the Company, each as presently in effect; (ii) resolutions of the Company’s Board of] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Registration Statement on Form S-8 of Skystar Bio-Pharmaceutical Company of our report dated March 30, 2012 relating to the consolidated financial statements appearing in the Annual Report on Form 10-K of Skystar Bio-Pharmaceutical Company for the year ended December 31, 2011. Sherman Oaks, California]
[China Zenix Filed Annual Report on Form 20-F for 2011 ZHANGZHOU, China, April 26, 2012 China Zenix Auto International Limitedout China Zenix Auto International Limited STYLE="font-family:Times New Roman" SIZE="2">China Zenix Auto International Limited is the largestmmercial vehicle wheel manufacturer in China in both the aftermarket andM market byles volume. With a large intellectual property portfolio,]
[CNOOC Limited]
[None Indicate the number of outstanding shares of each of the issuers classes of capital or common stock as of the close of the period covered by the annual report: 133,505,836 Ordinary Shares o Yes x No o Yes x No x Yes o No o Yes o No Large accelerated filer o Accelerated filer x Non-accelerated filer o U.S.] [Beijing Weland International Education and Technology Corp. Share Transfer Framework Agreement Among Zhang Tian Xu Heng Beijing Xueda Information Technology Co., Ltd. Chen Li and Song Junbo March 30, 2012 1 TABLE OF CONTENT SECTION 1 DEFINITION 4 SECTION 2 FUNDAMENTAL TRANSACTION ARRANGEMENT 5 SECTION 3 SHARE TRANSFER AND PAYMENT ARRANGEMENT RELATED TO SHARE TRANSFER 5 SECTION 4 HANDOVER 7] [List of Subsidiaries Name Jurisdiction of Incorporation Wholly-Owned Subsidiaries China Xueda Corporation Limited Hong Kong Xuecheng Century (Beijing) Information Technology Co., Ltd. China Beijing Xueda Education & Training Consulting Co., Ltd. China Consolidated Affiliated Entities Beijing Xueda Information Technology Co., Ltd. China EX-8.1 3 a12-6680_1ex8d1.htm EX-8.1] [Certification by the Chief Executive Officer I, Xin Jin, certify that: 1. I have reviewed this annual report on Form 20-F of Xueda Education Group; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [Certification by the Chief Financial Officer I, Junfeng Gao, certify that: 1. I have reviewed this annual report on Form 20-F of Xueda Education Group; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [Certification by the Chief Executive Officer (b) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. EX-13.1 6 a12-6680_1ex13d1.htm EX-13.1] [Certification by the Chief Financial Officer (b) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. EX-13.2 7 a12-6680_1ex13d2.htm EX-13.2] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statement No. 333-171434 on Form S-8 of our reports dated April 27, 2012, relating to the consolidated financial statements of Xueda Education Group, its subsidiaries, its variable interest entity (the VIE) and its VIEs subsidiaries (collectively, the Group), and the effectiveness of the]
[Lentuo International Announces Fourth Quarter and Fiscal 2011 Financial Results Company reports 38.6% sequential quarterly revenue growth BEIJING April 27 , 2012 Lentuo International Inc. (NYSE: LAS) (Lentuo or the Company), the largest non-state-owned automobile retailer in Beijing as measured by new vehicle sales revenue in 2010 , today announced its unaudited financial results for the fourth quarter] [FORM 6-K LENTUO INTERNATIONAL INC. Building D, 2nd Floor, 56 East 4th Ring South Road Chaoyang District, Beijing 100023 Peoples Republic of China (86-10) 6778 3955 (Address of Principal Executive Offices) reports under cover of Form 20-F or Form 40-F.) Form 20-F x Form 40-F o Yes o No x Yes o No x Yes o No x S]
[China Biologic Has Announced the Resignation of CFO Y. Tristan Kuo and Named Mr. Ming Yang as Interim CFO BEIJING, China, April 27, 2012 /PRNewswire via COMTEX/ China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China, today announced the resignation of Chief Financial Officer, Mr.] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): April 26, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Taian City, Shandong, 271000 Peoples Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former address, if changed]
[PART I INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS PARTII INFORMATION REQUIRED IN THE REGISTRATION STATEMENT Item 3.orporation of Documents by Reference. The following documents areorporated by reference in this Registration Statement: (a) Thempanys Annual Report on Form 10-K for the fiscal year ended December 31, 2011, filed with themmission on March 30, 2012;] [[Cozen OConnor Letterhead] April 27, 2012ystar Bio-Pharmaceuticalmpany 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xian, Shaanxi Province, P.R. China Re: Registration Statement on Form S-8 In rendering this opinion, we have examined: (i) the Articles oforporation and By-laws of thempany, each presently in effect; (ii) resolutions of thempanys Board of Directors] [Consent of Independent Registered Public Accounting Firm Wensent to theorporation by reference in this Registration Statement on Form S-8 ofystar Bio-Pharmaceuticalmpany of our reportted March 30, 2012 relating to thensolidated financial statements appearing in the Annual Report on Form 10-K ofystar Bio-Pharmaceuticalmpany for the year ended December 31, 2011.]
